Exploring (2R,3S)-3-Phenylisoserine: A Key Intermediate for Cabazitaxel
Discover the vital role of this chiral compound in advanced cancer therapy synthesis.
Get a Quote & SampleProduct Core Value
(2R,3S)-3-Phenylisoserine
This compound is a critical building block in the synthesis of Cabazitaxel, a vital chemotherapy drug used in the treatment of metastatic prostate cancer. Its precise stereochemistry is essential for the efficacy of the final therapeutic agent.
- Leverage the 3-Phenylisoserine manufacturer China expertise for your Cabazitaxel intermediate supply chain needs.
- Benefit from the high purity (>=98.0%) of this chiral compound, crucial for demanding pharmaceutical synthesis.
- Understand the chemical properties of 3-Phenylisoserine to optimize its handling and reaction pathways in your R&D.
- Explore the diverse applications of 3-Phenylisoserine in drug development beyond its primary role in oncology.
Advantages You Gain
Enhanced Therapeutic Efficacy
By serving as a key intermediate for Cabazitaxel production, it directly contributes to more effective oncology drug development and treatment outcomes.
Reliable Sourcing Options
Access a dependable supply of this critical component from established 3-Phenylisoserine manufacturers in China, ensuring continuity for your research and production.
Precision in Synthesis
The compound's defined chiral structure supports stereoselective reactions, vital for creating complex pharmaceutical molecules with targeted biological activity.
Key Applications
Cabazitaxel Synthesis
The primary use is as a direct precursor in the multi-step synthesis of Cabazitaxel, a taxane-based chemotherapy agent.
Oncology Drug Development
Essential for creating advanced cancer therapies, contributing to the fight against diseases like metastatic prostate cancer.
Pharmaceutical Synthesis
Serves as a versatile chiral intermediate for various complex organic molecules within the pharmaceutical industry.
Drug Discovery Research
Its unique structure makes it valuable for researchers exploring novel compounds and synthesis pathways in medicinal chemistry.